IC
NMRA icon

IEQ Capital’s Neumora Therapeutics NMRA Stock Holding History

IEQ Capital’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,173
Closed -$23.6K – 2020
2025
Q4 		$23.6K Sell
13,173
-4,284
-25% -$9.38K ﹤0.01% 1823
2025
Q3 		$31.8K Sell
17,457
-48,736
-74% -$78.8K ﹤0.01% 1816
2025
Q2 		$48.5K Buy
66,193
+39,680
+150% +$30.1K ﹤0.01% 1766
2025
Q1 		$26.5K Sell
26,513
-10,340
-28% -$17.7K ﹤0.01% 1582
2024
Q4 		$391K Sell
36,853
-38,000
-51% -$455K ﹤0.01% 930
2024
Q3 		$989K Sell
74,853
-8,000
-10% -$93.3K 0.01% 549
2024
Q2 		$814K Hold
82,853
– – 0.01% 526
2024
Q1 		$1.14M Buy
+82,853
New +$1.34M 0.02% 432

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return